Detalles de la búsqueda
1.
Pretreatment systemic inflammatory markers predict survival in endometrial cancer: A Japanese Gynecologic Oncology Group 2043 exploratory data analysis.
Gynecol Oncol
; 181: 46-53, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113633
2.
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Int J Clin Oncol
; 29(5): 512-534, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38493447
3.
Questionnaire survey regarding current status of minimally invasive surgery for endometrial cancer in Japan: A cross-sectional survey for JSGOE members.
J Obstet Gynaecol Res
; 49(9): 2370-2378, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37365774
4.
Correlation between the risk of ovarian cancer and BRCA recurrent pathogenic variants in Japan.
J Hum Genet
; 67(5): 267-272, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34983974
5.
Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan.
Int J Clin Oncol
; 27(2): 427-433, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34873649
6.
Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients.
Int J Clin Oncol
; 27(2): 441-447, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34648082
7.
A prospective cohort study on the safety and efficacy of bevacizumab combined with chemotherapy in Japanese patients with relapsed ovarian, fallopian tube or primary peritoneal cancer.
Jpn J Clin Oncol
; 51(1): 54-59, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776094
8.
A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer.
Int J Clin Oncol
; 26(10): 1977-1985, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34189636
9.
The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study.
World J Surg Oncol
; 19(1): 36, 2021 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33531027
10.
A Possible Inhibitory Role of Sialic Acid on MUC1 in Peritoneal Dissemination of Clear Cell-Type Ovarian Cancer Cells.
Molecules
; 26(19)2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34641504
11.
Risk factors for lymph node metastasis of ovarian, fallopian tube and primary peritoneal cancer in hereditary breast and ovarian cancer syndrome.
Jpn J Clin Oncol
; 50(12): 1380-1385, 2020 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676635
12.
Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open-label phase 2 trial.
Cancer Sci
; 110(9): 2894-2904, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31348579
13.
Analysis of the relapse patterns and risk factors of endometrial cancer following postoperative adjuvant chemotherapy in a phase III randomized clinical trial.
Gynecol Oncol
; 155(3): 413-419, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601493
14.
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
J Hum Genet
; 63(4): 447-457, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29176636
15.
Correction: Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
J Hum Genet
; 63(4): 541-542, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29386572
16.
Multicenter Clinicopathological Study of High-Grade Serous Carcinoma Presenting as Primary Peritoneal Carcinoma.
Int J Gynecol Cancer
; 28(4): 657-665, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29324533
17.
Clinical utility of a self-administered questionnaire for assessment of hereditary gynecologic cancer.
Jpn J Clin Oncol
; 47(5): 401-406, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28334914
18.
Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer.
Jpn J Clin Oncol
; 47(11): 1019-1023, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28973541
19.
UGT1A1 polymorphism as a prognostic indicator of stage I ovarian clear cell carcinoma patients treated with irinotecan.
Jpn J Clin Oncol
; 47(2): 170-174, 2017 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28173214
20.
A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial Cancer.
Int J Gynecol Cancer
; 27(7): 1517-1524, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28562470